TipRanks
Concord Biotech Ltd. (IN:CONCORDBIO)
:CONCORDBIO
India Market
CONCORDBIO
Concord Biotech Ltd.
RESEARCH TOOLSreports
Want to see IN:CONCORDBIO full AI Analyst Report?

Concord Biotech Ltd. (CONCORDBIO) Ratios

4 Followers

Concord Biotech Ltd. Ratios

IN:CONCORDBIO's free cash flow for Q1 2027 was ₹0.41. For the 2027 fiscal year, IN:CONCORDBIO's free cash flow was decreased by ₹ and operating cash flow was ₹0.25. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 6.40 7.39 6.17 6.30 3.79
Quick Ratio
 4.43 5.46 4.87 4.84 2.69
Cash Ratio
 0.04 0.08 <0.01 0.11 0.02
Solvency Ratio
 1.40 1.53 1.92 2.07 1.31
Operating Cash Flow Ratio
 0.75 1.59 1.34 1.87 1.28
Short-Term Operating Cash Flow Coverage
 531.05 0.00 649.20 42.61 9.84
Net Current Asset Value
₹ 10.36B₹ 10.31B₹ 9.14B₹ 7.22B₹ 5.04B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 0.02
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 0.02
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 0.02
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 <0.01
Financial Leverage Ratio
 1.12 1.11 1.12 1.11 1.17
Debt Service Coverage Ratio
 636.33 1.18K 273.97 35.71 7.93
Interest Coverage Ratio
 1.40K 1.03K 577.89 166.74 56.71
Debt to Market Cap
 <0.01 0.00 <0.01 <0.01 <0.01
Interest Debt Per Share
 0.19 0.25 0.38 1.23 3.89
Net Debt to EBITDA
 -0.01 -0.03 <0.01 -0.01 0.08
Profitability Margins
Gross Profit Margin
42.39%41.87%64.03%65.61%77.49%
EBIT Margin
29.96%32.70%38.34%38.03%35.15%
EBITDA Margin
36.35%39.76%42.72%43.13%41.33%
Operating Profit Margin
28.15%27.77%50.16%51.26%60.71%
Pretax Profit Margin
31.96%32.67%41.21%40.57%37.74%
Net Profit Margin
24.13%24.73%30.97%30.30%28.14%
Continuous Operations Profit Margin
23.87%24.57%30.97%30.30%28.14%
Net Income Per EBT
75.51%75.70%75.15%74.68%74.56%
EBT Per EBIT
113.52%117.65%82.15%79.15%62.17%
Return on Assets (ROA)
12.14%11.68%18.27%18.12%15.86%
Return on Equity (ROE)
14.24%12.93%20.50%20.18%18.61%
Return on Capital Employed (ROCE)
15.50%14.18%32.54%33.44%39.18%
Return on Invested Capital (ROIC)
11.58%10.66%24.42%24.85%28.66%
Return on Tangible Assets
12.17%11.68%18.28%18.12%15.86%
Earnings Yield
2.17%2.43%2.14%1.98%2.43%
Efficiency Ratios
Receivables Turnover
 2.84 2.29 2.30 2.91 2.73
Payables Turnover
 6.01 6.02 3.82 3.70 2.05
Inventory Turnover
 1.69 1.88 1.80 1.68 0.90
Fixed Asset Turnover
 1.34 1.22 1.42 1.29 1.11
Asset Turnover
 0.50 0.47 0.59 0.60 0.56
Working Capital Turnover Ratio
 2.15 1.04 1.41 1.58 1.68
Cash Conversion Cycle
 283.28 292.82 265.71 243.95 359.08
Days of Sales Outstanding
 128.64 159.23 158.66 125.48 133.87
Days of Inventory Outstanding
 215.35 194.25 202.63 217.02 403.45
Days of Payables Outstanding
 60.70 60.66 95.57 98.55 178.24
Operating Cycle
 343.99 353.48 361.28 342.50 537.32
Cash Flow Ratios
Operating Cash Flow Per Share
 14.44 25.58 23.65 25.38 23.51
Free Cash Flow Per Share
 9.33 16.54 13.02 17.18 9.65
CapEx Per Share
 5.11 9.04 10.63 8.19 13.87
Free Cash Flow to Operating Cash Flow
 0.65 0.65 0.55 0.68 0.41
Dividend Paid and CapEx Coverage Ratio
 0.91 1.30 1.22 1.69 1.24
Capital Expenditure Coverage Ratio
 2.82 2.83 2.23 3.10 1.70
Operating Cash Flow Coverage Ratio
 86.35 116.29 83.32 27.26 7.80
Operating Cash Flow to Sales Ratio
 0.13 0.26 0.21 0.26 0.29
Free Cash Flow Yield
0.75%1.62%0.78%1.15%1.02%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 46.20 41.10 46.82 50.53 41.08
Price-to-Sales (P/S) Ratio
 11.13 10.16 14.50 15.31 11.56
Price-to-Book (P/B) Ratio
 6.28 5.32 9.60 10.20 7.65
Price-to-Free Cash Flow (P/FCF) Ratio
 133.53 61.58 127.69 86.60 97.74
Price-to-Operating Cash Flow Ratio
 86.25 39.82 70.31 58.65 40.09
Price-to-Earnings Growth (PEG) Ratio
 -3.61 -1.36 2.27 1.78 1.10
Enterprise Value Multiple
 30.62 25.54 33.93 35.49 28.05
Enterprise Value
 130.25B 107.11B 173.98B 155.63B 98.91B
EV to EBITDA
 30.62 25.54 33.93 35.49 28.05
EV to Sales
 11.13 10.15 14.50 15.30 11.59
EV to Free Cash Flow
 133.48 61.51 127.71 86.57 98.01
EV to Operating Cash Flow
 86.21 39.78 70.32 58.63 40.21
Tangible Book Value Per Share
 197.51 191.22 173.17 145.90 123.29
Shareholders’ Equity Per Share
 198.42 191.57 173.27 145.93 123.31
Tax and Other Ratios
Effective Tax Rate
 0.25 0.25 0.25 0.25 0.25
Revenue Per Share
 111.88 100.19 114.71 97.21 81.55
Net Income Per Share
 27.00 24.78 35.52 29.45 22.95
Tax Burden
 0.76 0.76 0.75 0.75 0.75
Interest Burden
 1.07 1.00 1.07 1.07 1.07
Research & Development to Revenue
 0.00 0.00 0.02 0.02 0.04
SG&A to Revenue
 0.14 0.14 0.12 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.47 1.03 0.67 0.86 1.02
Currency in INR